Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

BREAKING: Can't wait to get stuck into my new role, says new pharmacy minister Maggie Throup

Maggie Throup, the Conservative Party MP for Erewash, is the new minister with responsibility for pharmacy.

She was appointed parliamentary under secretary of state for Prevention, Public Health and Primary Care on Thursday (September 16) following a cabinet reshuffle by prime minister Boris Johnson which saw her predecessor Jo Churchill moved to Defra.


"Honoured to have been appointed public health minister at such a critical moment for our country as we begin the huge task of building back better from the pandemic," Throup announced on Twitter following confirmation of her appointment which will also see her assume the responsibility of vaccine deployment after the minister in charge, Nadhim Zawahi, was elevated as education secretary during the same reshuffle.

The new pharmacy minister tweeted that she can’t wait to get stuck into her new portfolio, rolling out the Covid vaccine booster programme and supporting prime minister Johnson and health secretary Sajid Javid "to deliver lasting reforms to health and social care."

https://twitter.com/maggie_erewash/status/1438575231652794374

The UK government announced on September 14 that some 30 million people were likely to be offered a third dose of Covid-19 vaccine, six months after their second dose as part of a booster programme.

Throup, a former government whip and a scientist by training, entered parliament in 2015 at the third time of trying.

Born on 27 January 1957 in Shipley, West Yorkshire, she went to a girls' grammar school in Bradford and studied biology at university before beginning her career at Calderdale Health Authority as a medical laboratory scientist. She moved into medical diagnostics sales and marketing with a pharmaceutical company before setting up her own consultancy business.

According to her website, Throup supports the wider use of diagnostic testing in order to reduce the amount of antibiotics that are wrongly prescribed. She is also credited for the establishment of the All Party Parliamentary Group on Obesity which she chairs.

In 2015, Throup was elected to serve on the House of Commons Health Select Committee, and has also previously served on the Scottish Affairs Select Committee.

More For You

Astrazeneca Office Building  Outlook

British Medical Journal has found data discrepancy during the crucial clinical trials of AstraZeneca's heart drug ticagrelor.

iStock

Top medics question trials of AstraZeneca's anti-clotting pill

The effectiveness of anti-clotting pill ticagrelor is now under a cloud, with some experts claiming that AstraZeneca misreported data when the trials were conducted more than a decade ago.

Sold as Brilinta, the pill was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack, and the generic versions of the drug are scheduled for this year.

Keep ReadingShow less
Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

iStock

Pensions Ombudsman probing Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

According to the Pharmacists' Defence Association (PDA), the ombudsman has decided to take a ‘lead case’ approach, as several members have been affected by the issue.

Keep ReadingShow less
23andMe

More than 150,000 UK residents had their personal information taken by hackers during a data breach in 2023.

iStock

UK watchdog fines 23andMe £2.31m for data breach

Genetic testing firm 23andMe has been fined £2.31 million by a UK watchdog over a 2023 data breach, when the personal information of seven million people across the world was stolen.

The Information Commissioner's Office (ICO) said the California-based company, which later filed for bankruptcy, failed to put adequate measures in place to secure sensitive user data.

Keep ReadingShow less
Henry Gregg, new Chief Executive of the National Pharmacy Association.
Henry Gregg
Henry Gregg

Community pharmacy voices need to be ‘heard really loud’, new NPA chief tells Pharmacy Business

Henry Gregg, the new chief executive of the National Pharmacy Association (NPA), believes community pharmacies have a right to have insight into discussions relating to the pharmacy funding contract.

Currently, Community Pharmacy England (CPE) solely negotiates the elements of the Community Pharmacy Contractual Framework (CPCF) with the Department of Health and Social Care (DHSC) and NHS England.

Keep ReadingShow less
Patient care

The NHS said the benefits were "too small to justify the additional cost"

NHS rejects Alzheimer's drugs shown to delay early-stage of disease

Two new treatments for Alzheimer's disease will not be offered on the NHS due to high costs and "too small" benefits.

Donanemab and Lecanemab have been hailed as breakthrough treatments for slowing down the symptoms of early-stage Alzheimer's, the most common type of dementia.

Keep ReadingShow less